PLUS1
0.86
0.19 (28.36%)
0.19 (28.36%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 8,627,941 |
|
|||||
| News | - | ||||||
| Day High | 0.949199 | Low High |
|||||
| Day Low | 0.73 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.19 | 28.36% | 0.86 | 11:53:34 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.7427 | 0.73 | 0.949199 | 0.89 | 0.67 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,386 | 8,627,941 | US$ 0.86056 | US$ 7,424,861 | - | 0.241 - 2.93 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:53:38 | 9 | US$ 0.86 | USD |
Period:
Draw Mode:
Akebia Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 158.21M | 183.96M | 181.99M | US$ 213.58M | US$ -76.48M | -1.70 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 2.40% |
Akebia Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 02/2/2023 | 08:05 | PR Newswire (US) | Akebia Therapeutics Reports Inducement Grants Under Nasdaq.. |
| 31/1/2023 | 08:07 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
| 21/1/2023 | 00:55 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 10/1/2023 | 00:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 04/1/2023 | 08:05 | PR Newswire (US) | Akebia Therapeutics Reports Inducement Grants Under Nasdaq.. |
| 29/12/2022 | 00:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 23/12/2022 | 00:45 | PR Newswire (US) | Akebia Therapeutics Received Interim Response to Appeal for.. |
| 20/12/2022 | 08:11 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 14/12/2022 | 08:04 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) |
| 03/12/2022 | 08:05 | PR Newswire (US) | Akebia Therapeutics Reports Inducement Grants Under Nasdaq.. |
| 23/11/2022 | 08:05 | PR Newswire (US) | Akebia Therapeutics to Participate in the Piper Sandler 34th.. |
| 11/11/2022 | 08:10 | Edgar (US Regulatory) | Current Report Filing (8-k) |
Historical AKBA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.73 | 0.949199 | 0.56 | 0.6547352 | 1,620,861 | 0.13 | 17.81% |
| 1 Month | 0.639 | 0.949199 | 0.56 | 0.6790183 | 1,371,112 | 0.221 | 34.59% |
| 3 Months | 0.25 | 0.949199 | 0.2425 | 0.4621699 | 1,778,978 | 0.61 | 244.0% |
| 6 Months | 0.379 | 0.949199 | 0.241 | 0.4045631 | 1,971,496 | 0.481 | 126.91% |
| 1 Year | 2.02 | 2.93 | 0.241 | 0.6870203 | 5,977,760 | -1.16 | -57.43% |
| 3 Years | 7.28 | 13.78 | 0.241 | 2.48 | 4,531,236 | -6.42 | -88.19% |
| 5 Years | 14.85 | 15.37 | 0.241 | 2.97 | 3,078,692 | -13.99 | -94.21% |